This report presents the top-level overview of the drug phenomenon in Poland, covering drug supply, use and public health problems as well as drug policy and responses. The statistical data reported relate to 2016 (or most recent year) and are provided to the EMCDDA by the national focal point, unless stated otherwise.
What are the long-term aims of drug policy in Poland? How are these aims to be achieved? How is drug policy coordinated at national level?
Understanding the costs of drug-related actions is an important aspect of policy evaluation.
What substances and activities does Poland control under its drug laws? What are the penalties for offences? How are new psychoactive substances controlled?
How many people in Poland have ever used drugs? What drugs have they used? How many have used drugs recently? How many are using drugs in highly risky ways?
What are the main infectious diseases linked to drug injecting in Poland? How many died of drug overdose in the last year? How many drug-related medical emergencies occurred?
What part does prevention play in Poland's drug strategy. What are the main prevention approaches used in the country and who do they target?
How does Poland measure in terms of provision of needle and syringe programmes, peer naloxone programmes, supervised drug consumption rooms and heroin-assisted treatment.
How is the drug treatment system organised in Poland? How is it financed? How is the provision of treatment divided between inpatient and outpatient settings?
Which authorities are responsible for prison health in Poland? What forms of drug treatment and harm reduction are provided in prisons, and how widely?
What is done in Poland to ensure that the prevention and treatment interventions used are effective and provide a good return on public expenditure?
In which areas of study is drug-related research carried out in Poland? How is this research funded? Are any types of research emphasised in the national drug strategy?
What is known about drug supply and trafficking in Poland? How pure or strong are the drugs available? What do they cost? What are the main aims of supply reduction efforts?
Key drug statistics for Poland
Focus on Poland